The pneumococcal protein conjugate vaccines

Journal of Pediatrics

Volumn 137, Issue 3, 2000, Pages 416-420

  Peters, Timothy R ^a   Edwards, Kathryn M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TETANUS TOXOID; DIPHTHERIA TOXOID; DIPHTHERIA VACCINE; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; TETANUS TOXOID;

ANTIBIOTIC RESISTANCE; BACTEREMIA; BACTERIAL MENINGITIS; CHILD; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOGENICITY; INFANT; MALE; OTITIS MEDIA; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0033827428     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.109114     Document Type: Article

References (42)

1. Acute respiratory infections in the developing world: Strategies for prevention, treatment and control
2. Emergence of vancomycin tolerance in Streptococcus pneumoniae
3. Six newly recognized types of Streptococcus pneumoniae
4. Pneumococcal polysaccharide vaccine efficacy
5. First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants
6. Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines
7. Thymus-independent and thymus-dependent responses to polysaccharide antigens
8. Pneumococcal disease: Prospects for a new generation of vaccines
9. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type B polysaccharide and Neisseria meningitidis outer-membrane protein complex
10. Efficacy of Haemophilus influenzae type B conjugate vaccine in Oxford region
11. Induction of immunologic memory in infants primed with Haemophilus influenzae type B conjugate vaccines
12. Bacterial meningitis in the United States in 1995
13. Achievements in public health, 1900-1999. Impact of vaccines universally recommended for children - United States, 1990-1999
14. Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States 1978-1994: Implications for development of a conjugate vaccine
15. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants
16. Potential interventions for the prevention of childhood pneumonia: Geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children implications for vaccine strategies
17. A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines in young children: Effect of polysaccharide size and linkage characteristics
18. Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants
19. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children
20. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants
21. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid
22. Streptococcus pneamoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory
23. 197 in United States infants
24. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers
25. Pneumococcal conjugate vaccines
26. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants
27. Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of salivary IgA antibody response
28. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
29. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine
30. Progress toward elimination of Haemophilus influenzae type B disease among infants and children - United States, 1987-1997
31. Invasive pneumococcal infection in children, 1981-92: A hospital-based study
32. A 20-year epidemiological study of pneumococcal meningitis
33. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
34. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
35. Office visits for otitis media: United States, 1975-90
36. Cost-effectiveness considerations in otitis media treatment
37. Efficacy of a heptavalent pneumococcal conjugate vaccine (PncCRM) against serotype-specific culture-confirmed pneumococcal acute otitis media (AOM) in infants and children
38. Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children
39. Carriage of pneumococci after pneumococcal vaccination
40. Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae
41. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneamoniae
42. Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae